Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK8 | P49336 | 2/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.33 |
| ▸ | FLT1 | P17948 | 1/20 | 0.33 |
| ▸ | CDK9 | P50750 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | PRKACA | P17612 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.33 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.33 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12952624 | 0.89 | CDK8 (0.32) | CDK8ROCK1FLT1CDK9LIMK1 | |
| SCHEMBL19510469 | 0.75 | CDK8 (0.38) | CDK8ROCK1FLT1CDK9LIMK1 | |
| SCHEMBL18184622 | 0.68 | — | — | |
| SCHEMBL22729976 | 0.67 | — | — | |
| SCHEMBL14463968 | 0.65 | — | — | |
| SCHEMBL5575387 | 0.65 | CDK8 (0.38) | CDK8ROCK1FLT1CDK9LIMK1 | |
| SCHEMBL18535906 | 0.65 | CA12 (0.32) | — | |
| SCHEMBL20924432 | 0.64 | GRIN2D (0.31) | — | |
| SCHEMBL14463965 | 0.62 | NOTUM (0.33) | — | |
| SCHEMBL19035432 | 0.61 | NPC1 (0.43) | FLT1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7854999-B2 | Organoelectroluminescent compound and organoelectroluminescent device employing the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-12-21 | — | — | US | disclosed |
| US-20080100207-A1 | Organoelectroluminescent compound and organoelectroluminescent device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080100207-A1 | Organoelectroluminescent compound and organoelectroluminescent device employing the same | PPOX, EML4, DDT | CDK8 324/4885ROCK1 1218/4885FLT1 2258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.